• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素是一种具有抗炎和抗氧化特性的化合物,可下调骨髓基质细胞中趋化因子的表达。

Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells.

作者信息

Xu Y X, Pindolia K R, Janakiraman N, Noth C J, Chapman R A, Gautam S C

机构信息

Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan 48202, USA.

出版信息

Exp Hematol. 1997 May;25(5):413-22.

PMID:9168063
Abstract

Chemotactic cytokines or chemokines play an important role in the regulation of myelopoiesis. Since the production of chemokines and colony stimulating factors (CSFs) by bone marrow stromal cells requires inflammatory conditions, we investigated the effect of curcumin, an agent with anti-inflammatory and anti-oxidant activities, on the expression of monocyte chemoattractant protein-1 (MCP-1 or MCP-1/JE) and interferon inducible protein-10kD (IP-10) in mouse bone marrow stromal cell line +/+-1.LDA11. Both chemokines are readily expressed in stromal cells after stimulation with pro-inflammatory interleukin-1alpha (IL-1alpha), interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and endotoxin lipopolysaccharide (LPS). Curcumin attenuates the levels of MCP-1/JE and IP-10 mRNA expression by all of these stimulatory agents. A detailed analysis of the regulatory effects of curcumin on chemokine expression by IL-1alpha was performed. Curcumin inhibits both chemokine mRNAs in a dose- and time-dependent manner. The suppressive effect of curcumin on both mRNAs is reversible with complete recovery from suppression within 24 hours after removal of curcumin. The suppression of mRNA by curcumin is dependent on de novo synthesis of an intermediary protein(s), since suppression is abrogated by concomitant treatment with cycloheximide (CHX). Destabilization of mRNA transcripts is not the mechanism by which curcumin lowers the levels of mRNA; however, transcripts formed in the presence of curcumin are more stable, as indicated by their slower degradation kinetics. Run-on transcriptional assays demonstrate that curcumin inhibits the transcriptional activity of both genes. Finally, the attenuation of chemokine gene expression is associated with decreased production of chemotactic activity. Together, these findings indicate that while curcumin may post-transcriptionally stabilize mRNA transcripts formed in its presence, the overall reduction in mRNA levels by curcumin is mediated by inhibition of the transcription of chemokine genes.

摘要

趋化性细胞因子或趋化因子在骨髓生成的调节中发挥着重要作用。由于骨髓基质细胞产生趋化因子和集落刺激因子(CSF)需要炎症条件,我们研究了姜黄素(一种具有抗炎和抗氧化活性的物质)对小鼠骨髓基质细胞系+/+-1.LDA11中单核细胞趋化蛋白-1(MCP-1或MCP-1/JE)和干扰素诱导蛋白-10kD(IP-10)表达的影响。在用促炎白细胞介素-1α(IL-1α)、干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)和内毒素脂多糖(LPS)刺激后,这两种趋化因子在基质细胞中均易于表达。姜黄素可降低所有这些刺激剂所诱导的MCP-1/JE和IP-10 mRNA表达水平。我们对姜黄素对IL-1α诱导的趋化因子表达的调节作用进行了详细分析。姜黄素以剂量和时间依赖性方式抑制这两种趋化因子的mRNA。姜黄素对两种mRNA的抑制作用是可逆的,在去除姜黄素后24小时内可从抑制状态完全恢复。姜黄素对mRNA的抑制作用依赖于中间蛋白的从头合成,因为用环己酰亚胺(CHX)同时处理可消除这种抑制作用。mRNA转录本的不稳定不是姜黄素降低mRNA水平所采用的机制;然而,如降解动力学较慢所示,在姜黄素存在下形成的转录本更稳定。核转录分析表明,姜黄素抑制这两个基因的转录活性。最后,趋化因子基因表达的减弱与趋化活性的产生减少有关。总之,这些发现表明,虽然姜黄素可能在转录后使在其存在下形成的mRNA转录本稳定,但姜黄素使mRNA水平总体降低是通过抑制趋化因子基因的转录介导的。

相似文献

1
Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells.姜黄素是一种具有抗炎和抗氧化特性的化合物,可下调骨髓基质细胞中趋化因子的表达。
Exp Hematol. 1997 May;25(5):413-22.
2
IL-4 upregulates IL-1-induced chemokine gene expression in bone marrow stromal cells by enhancing NF-kB activation.白细胞介素-4通过增强核因子-κB的激活,上调骨髓基质细胞中白细胞介素-1诱导的趋化因子基因表达。
Hematopathol Mol Hematol. 1996;10(4):171-85.
3
Induction of chemokine mRNA in bone marrow stromal cells: modulation by TGF-beta 1 and IL-4.骨髓基质细胞中趋化因子mRNA的诱导:转化生长因子-β1和白细胞介素-4的调节作用
Exp Hematol. 1995 Jun;23(6):482-91.
4
Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo.脂多糖在体外和体内对巨噬细胞趋化因子表达的调控
J Immunol. 1999 Aug 1;163(3):1537-44.
5
Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.粒细胞-巨噬细胞集落刺激因子的表达在小鼠骨髓基质细胞系中受到转录和转录后水平的调控。
Exp Hematol. 1994 Aug;22(9):924-32.
6
Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers.化疗后患者及体外细胞因子处理的骨髓基质细胞层中血小板生成素和趋化因子mRNA表达
Stem Cells. 2000;18(5):331-42. doi: 10.1634/stemcells.18-5-331.
7
Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.抗炎剂对人血单核细胞合成MCP-1/JE转录物的影响。
Mol Pharmacol. 1992 Jul;42(1):63-8.
8
IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages.γ干扰素选择性抑制小鼠腹腔巨噬细胞中脂多糖诱导的JE/单核细胞趋化蛋白-1和KC/GRO/黑素瘤生长刺激活性基因的表达。
J Immunol. 1994 Sep 1;153(5):2204-12.
9
Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells.姜黄素抑制骨髓基质细胞中白细胞介素1α和肿瘤坏死因子α诱导的AP-1和核因子κB DNA结合活性。
Hematopathol Mol Hematol. 1997;11(1):49-62.
10
Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes.原代培养小鼠肝细胞中趋化因子JE、KC和IP-10基因的差异表达与调控
J Cell Physiol. 1999 Nov;181(2):361-70. doi: 10.1002/(SICI)1097-4652(199911)181:2<361::AID-JCP18>3.0.CO;2-9.

引用本文的文献

1
Therapeutic Effects of Nanochelating-Based Copper Nanoparticles on Burn Wound Healing in Mouse Model.基于纳米螯合的铜纳米颗粒对小鼠模型烧伤创面愈合的治疗作用
Avicenna J Med Biotechnol. 2025 Jan-Mar;17(1):2-13. doi: 10.18502/ajmb.v17i1.17672.
2
Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis.降低与肥胖相关的趋化因子可归咎于转移的营养物质。
Int J Mol Sci. 2025 Mar 4;26(5):2275. doi: 10.3390/ijms26052275.
3
Curcumin and Its Derivatives as Potential Antimalarial and Anti-Inflammatory Agents: A Review on Structure-Activity Relationship and Mechanism of Action.
姜黄素及其衍生物作为潜在的抗疟和抗炎剂:结构-活性关系及作用机制综述
Pharmaceuticals (Basel). 2023 Apr 18;16(4):609. doi: 10.3390/ph16040609.
4
Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis.基于生物信息学分析探讨姜黄素对非酒精性脂肪性肝病中蛋白质靶标的作用。
Nutrients. 2022 Mar 22;14(7):1331. doi: 10.3390/nu14071331.
5
Self-oxygenation mesoporous MnO nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy.具有超高载药能力的自供氧介孔 MnO 纳米颗粒用于靶向动脉粥样硬化治疗。
J Nanobiotechnology. 2022 Feb 19;20(1):88. doi: 10.1186/s12951-022-01296-x.
6
Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis.姜黄素通过整合 miRNA/mRNA 表达分析改变乳腺癌亚型中的不同分子途径。
Cancer Rep (Hoboken). 2022 Oct;5(10):e1596. doi: 10.1002/cnr2.1596. Epub 2022 Jan 4.
7
A Novel Curcumin-Based Drug Powder Inhalation Medicine for Chronic Obstructive Pulmonary Disease.一种用于慢性阻塞性肺疾病的新型姜黄素类药物粉末吸入剂
Bioinorg Chem Appl. 2021 Nov 29;2021:8001787. doi: 10.1155/2021/8001787. eCollection 2021.
8
Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report.脐血细胞移植和给予姜黄素后一名泰-萨克斯病患者血浆中的血清细胞因子谱、β-己糖胺酶A酶活性及GM神经节苷脂水平:病例报告
Life (Basel). 2021 Sep 24;11(10):1007. doi: 10.3390/life11101007.
9
Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.姜黄素在骨肉瘤治疗中的应用:与免疫疗法、化疗药物、骨组织工程材料联合应用及与光动力疗法的潜在协同作用
Front Oncol. 2021 May 20;11:672490. doi: 10.3389/fonc.2021.672490. eCollection 2021.
10
Role of IP3 Receptors in Shaping the Carotid Chemoreceptor Response to Hypoxia But Not to Hypercapnia in the Rat Carotid Body: An Evidence Review.IP3 受体在塑造颈动脉体化学感受器对低氧反应而非高碳酸血症反应中的作用:证据综述。
Adv Exp Med Biol. 2021;1289:1-25. doi: 10.1007/5584_2020_561.